TY - JOUR AU - Takahashi, Kenichiro AU - Ishikane, Masahiro AU - Ujiie, Mugen AU - Iwamoto, Noriko AU - Okumura, Nobumasa AU - Sato, Testsuro AU - Nagashima, Maki AU - Moriya, Ataru AU - Suzuki, Michiyo AU - Hojo, Masayuki AU - Kanno, Takayuki AU - Saito, Shinji AU - Miyamoto, Sho AU - Ainai, Akira AU - Tobiume, Minoru AU - Arashiro, Takeshi AU - Fujimoto, Tsuguto AU - Saito, Tomoya AU - Yamato, Masaya AU - Suzuki, Tadaki AU - Ohmagari, Norio T1 - Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees T2 - Emerging Infectious Disease journal PY - 2022 VL - 28 IS - 5 SP - 998 SN - 1080-6059 AB - To determine virus shedding duration, we examined clinical samples collected from the upper respiratory tracts of persons infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in Japan during November 29–December 18, 2021. Vaccinees with mild or asymptomatic infection shed infectious virus 6–9 days after onset or diagnosis, even after symptom resolution. KW - COVID-19 KW - 2019 novel coronavirus disease KW - coronavirus disease KW - severe acute respiratory syndrome coronavirus 2 KW - SARS-CoV-2 KW - viruses KW - respiratory infections KW - zoonoses KW - Omicron KW - variant of concern KW - viral shedding KW - vaccines KW - Japan DO - 10.3201/eid2805.220197 UR - https://wwwnc.cdc.gov/eid/article/28/5/22-0197_article ER - End of Reference